Latest Cancer News

Targeted Radiation with 177Lu-PSMA-617 is Promising Treatment for Advanced Prostate Cancer (12-31-2018)
177Lu-PSMA-617 is a member of a new class of drugs that deliver radiation directly to tumor cells to obliterate them. These targeted radiation treatments consist of a radioactive isotope attached to a... Continue Reading

Immunotherapy Offers New Hope in Triple Negative Breast Cancer (12-28-2018)
Results from the Impassion 130 clinical trial published in the New England Journal of Medicine have demonstrated that immunotherapy can improve survival in breast cancer, especially in anti-programmed... Continue Reading

Herceptin Biosimilar Herzuma Approved for Certain Breast Cancer Indications (12-21-2018)
The FDA has approved Celltrion and Teva’s Herzuma (trastuzumab-pkrb), a biosimilar trastuzumab referencing Herceptin, for the treatment of HER2-positive breast cancer. Herzuma is the second oncology... Continue Reading

More Cancer News

Patient Resources

VirtualTour_280x99

CoC Logo 541 ACCREDITED PROGRAM caps